These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31590145)

  • 1. Imaging of brain glucose uptake by PET in obesity and cognitive dysfunction: life-course perspective.
    Iozzo P; Guzzardi MA
    Endocr Connect; 2019 Nov; 8(11):R169-R183. PubMed ID: 31590145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline-Does Insulin Have Anything to Do with It? A Narrative Review.
    Rebelos E; Rinne JO; Nuutila P; Ekblad LL
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
    Blautzik J; Kotz S; Brendel M; Sauerbeck J; Vettermann F; Winter Y; Bartenstein P; Ishii K; Rominger A;
    J Alzheimers Dis; 2018; 65(3):781-791. PubMed ID: 28697560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-carotid endarterectomy changes in cerebral glucose metabolism on (18)F-fluorodeoxyglucose positron emission tomography associated with postoperative improvement or impairment in cognitive function.
    Yoshida K; Ogasawara K; Saura H; Saito H; Kobayashi M; Yoshida K; Terasaki K; Fujiwara S; Ogawa A
    J Neurosurg; 2015 Dec; 123(6):1546-54. PubMed ID: 26230467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
    Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
    JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Effect of Fatty Diet and Cognitive Decline on Brain Metabolism, Food Intake, Body Weight, and Counteraction by Intranasal Insulin Therapy in 3×Tg Mice.
    Sanguinetti E; Guzzardi MA; Panetta D; Tripodi M; De Sena V; Quaglierini M; Burchielli S; Salvadori PA; Iozzo P
    Front Cell Neurosci; 2019; 13():188. PubMed ID: 31130848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer's disease.
    Carter SF; Chiotis K; Nordberg A; Rodriguez-Vieitez E
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):348-356. PubMed ID: 30515545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered Brain Glucose Metabolism Assessed by
    Su J; Huang Q; Ren S; Xie F; Zhai Y; Guan Y; Liu J; Hua F
    Neuroscience; 2019 Oct; 417():35-44. PubMed ID: 31394195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.
    Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S
    Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment.
    Eguchi A; Kimura N; Aso Y; Yabuuchi K; Ishibashi M; Hori D; Sasaki Y; Nakamichi A; Uesugi S; Jikumaru M; Sumi K; Shimomura T; Matsubara E
    Curr Alzheimer Res; 2019; 16(9):852-860. PubMed ID: 31385770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
    Bokde AL; Teipel SJ; Drzezga A; Thissen J; Bartenstein P; Dong W; Leinsinger G; Born C; Schwaiger M; Moeller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2005; 20(6):352-7. PubMed ID: 16192725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Glucose Metabolism is Associated with Verbal but not Visual Memory Performance in Community-Dwelling Older Adults.
    Gardener SL; Sohrabi HR; Shen KK; Rainey-Smith SR; Weinborn M; Bates KA; Shah T; Foster JK; Lenzo N; Salvado O; Laske C; Laws SM; Taddei K; Verdile G; Martins RN
    J Alzheimers Dis; 2016 Mar; 52(2):661-72. PubMed ID: 27031482
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.